New Delhi : The country is adopting all kinds of maneuvers to fight Corona and one of these is the Warm Vaccine. In order to further strengthen this fight against the corona epidemic and to get more and more people vaccinated, a warm vaccine may soon come to the country. If all goes well, then in the coming days the country will get the warm corona vaccine. (Warm vaccine may come soon in the country, know what is special in it and how will it be effective)
Increase the speed of vaccination
Warm corona vaccine, which will not require any special arrangement to keep it. This will make it easier to carry it anywhere, which will help in increasing the speed of vaccination. A startup of the prestigious Indian Institute of Science (IISc), Bangalore, has developed this vaccine, which has been found to be effective against all major variants of corona in tests on rats and hamsters. Now it is yet to be tested on humans.
What is warm vaccine, how is it different from other vaccines?
Most vaccines around the world need to be kept in the refrigerator to remain effective. For example, the Oxford-AstraZeneca vaccine requires a refrigerator at 2-8 °C for the shield and minus 70 °C for the Pfizer vaccine. But on the other hand the warm vaccine will be safe for a month at 37 °C temperature and will not spoil for one and a half hours at 100 °C temperature. For this reason it has been named Warm Vaccine or Warm Vaccine.
may prove to be a milestone
This vaccine can prove to be a milestone in terms of vaccination. This vaccine developed by IISc’s startup, important for hot weather countries, is a ‘warm vaccine’. CSIRO’s director of health and biosafety, Rob Grenfell, has said that the thermostable or heated vaccine is very important for vaccination in remote areas with hot weather. This vaccine will prove to be important for the remote rural areas of Australia as well as the Indo-Pacific region. Apart from this, keeping warm vaccine or hot vaccine will also be useful in such places where there is no facility of refrigerator and other resources.
able to fight corona
According to a research report published on Thursday in the journal ACS Infectious Disease, this anti-corona vaccine formula developed by IISc start-up Mynvax has produced strong immunity in mice. According to SS Vasan, leader of CSIRO’s Kovid-19 project and co-author of the study, this vaccine was used on rat sera.
In this, the vaccine produced strong immunity against all existing variants of the corona virus, including Delta. The study found that the antibody produced by this vaccine is also capable of inhibiting the alpha, beta, gamma variants of SARS-Cov-2. However, this vaccine has not been tested on humans at the moment. The institute is busy in preparations for this.